{"product_id":"masimo-marketing-mix","title":"Masimo Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReady-Made Marketing Analysis, Ready to Use\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Masimo’s product innovation, pricing strategy, distribution channels, and promotional mix combine to drive clinical and commercial success—get the full 4Ps Marketing Mix Analysis in an editable, presentation-ready format to save hours of research and apply strategic insights immediately.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSignal Extraction Technology Pulse Oximetry\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMasimo Signal Extraction Technology (SET) remains the gold standard in noninvasive pulse oximetry, delivering accurate SpO2 and pulse-rate readings during motion and low perfusion; clinical studies show SET cuts false alarms by ~60% versus conventional oximetry. By end-2025, SET underpins Masimo’s bedside and handheld portfolio sold in 110+ countries, driving recurring sensor revenue—Masimo reported 2024 device-related revenue growth of ~8% year-over-year. Clinicians rely on SET to flag true physiological events faster, reducing unnecessary interventions and alarm fatigue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRainbow Pulse CO-Oximetry Platform\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Rainbow Pulse CO-Oximetry Platform noninvasively measures multiple blood constituents—SpO2, total hemoglobin (tHb), carboxyhemoglobin (COHb)—enabling continuous monitoring once only possible via invasive draws. \u003c\/p\u003e\n\u003cp\u003eContinuous tHb monitoring cuts lab draws by up to 40% in trials, reducing transfusion delays and improving OR throughput; Masimo reported Rainbow platform revenue growth of ~18% in FY2024. \u003c\/p\u003e\n\u003cp\u003eAs of 2025, new sensors improved precision and response time—CV for tHb now ~1.5% and reporting latency under 10 seconds—boosting ICU and perioperative adoption. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRoot Connectivity and Patient Monitoring Hub\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRoot is Masimo’s clinician-centric monitoring and connectivity hub that consolidates multiple technologies into one interface, cutting charting time—studies show automation to EHRs can reduce documentation errors by up to 70% and save nurses ~30 minutes per shift (2024 hospital workflow data). Its modular MOC-9 slots let hospitals scale monitoring capability as needs change, lowering upgrade capex by an estimated 20% versus full-system replacements (Masimo 2025 channel pricing analysis).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWearable and Telehealth Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMasimo expanded into medical-grade wearables with Radius VSM and Stork baby monitor, enabling continuous post-acute and at-home monitoring and supporting decentralized care and RPM (remote patient monitoring).\u003c\/p\u003e\n\u003cp\u003eBy late 2025 these devices report ~30% longer battery life and integrated cloud analytics; Masimo cited \u0026gt;15% revenue growth from new wearables in FY2024–25, driving higher recurring SaaS-style data services.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRadius VSM, Stork: continuous at-home\/post-acute use\u003c\/li\u003e\n\u003cli\u003eLate‑2025: ~30% better battery life, cloud analytics\u003c\/li\u003e\n\u003cli\u003eFY2024–25: wearables contributed \u0026gt;15% incremental revenue\u003c\/li\u003e\n\u003cli\u003eSupports remote patient management and RPM uptake\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrain Function and Capnography Monitoring\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMasimo’s product line includes SedLine brain function monitoring and NomoLine capnography, delivering real-time data on anesthesia depth and respiratory status for ORs and ICUs.\u003c\/p\u003e\n\u003cp\u003eClinical studies show SedLine reduces intraoperative awareness risk and NomoLine tracks ETCO2 with ±2 mmHg accuracy; together they expand Masimo’s physiological monitoring across high-acuity care.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSupports anesthesia depth + respiratory monitoring\u003c\/li\u003e\n\u003cli\u003eETCO2 accuracy ±2 mmHg\u003c\/li\u003e\n\u003cli\u003eReduces intraop awareness risk (studies)\u003c\/li\u003e\n\u003cli\u003eIntegrates into Masimo’s multi-parameter platform\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMasimo: Strong FY25 growth—SET cuts false alarms 60%, Rainbow\/tHb accuracy \u0026amp; wearables soar\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMasimo’s portfolio centers on SET pulse oximetry, Rainbow multigas\/tHb, Root hub, wearables (Radius VSM, Stork), SedLine and NomoLine; FY2024–25 device revenue grew ~8%, Rainbow ~18%, wearables \u0026gt;15%, and sensors\/recurring revenue drives margins. Clinical data: SET cuts false alarms ~60%, continuous tHb cuts lab draws ~40%; tHb CV ~1.5%, latency \u0026lt;10s; ETCO2 ±2 mmHg.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003eFY24–25 growth\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSET\u003c\/td\u003e\n\u003ctd\u003efalse alarms −60%\u003c\/td\u003e\n\u003ctd\u003edevice rev +8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRainbow\u003c\/td\u003e\n\u003ctd\u003etHb CV ~1.5%, latency \u0026lt;10s\u003c\/td\u003e\n\u003ctd\u003e+18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWearables\u003c\/td\u003e\n\u003ctd\u003ebattery +30%, cloud analytics\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNomoLine\/SedLine\u003c\/td\u003e\n\u003ctd\u003eETCO2 ±2 mmHg, reduced awareness\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into Masimo’s Product, Price, Place, and Promotion strategies, grounded in actual brand practices and competitive context for clear strategic implications.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Masimo’s 4P marketing insights into a concise, leadership-ready snapshot that clarifies product positioning, pricing strategy, distribution channels, and promotional focus to relieve strategic alignment pain points.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Sales Force in Major Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMasimo uses a highly trained direct sales force in key markets—notably the United States and Western Europe—covering roughly 60% of revenue in 2024 (Masimo interim report, 2024). This team manages hospital accounts and builds deep ties with administrators and clinical leaders, improving contract renewal rates; Masimo reported a commercial customer retention above 85% in major markets in 2024. The direct model delivers consistent technical support and clinical training, supporting \u0026gt;1,200 high-volume health systems worldwide and driving higher attach rates for consumables and software.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Distributor Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMasimo uses a network of specialized medical-device distributors across Asia-Pacific, Latin America, and the Middle East, leveraging partners' local market expertise and logistics to scale quickly without full regional offices.\u003c\/p\u003e\n\u003cp\u003eThis hybrid model cut incremental SG\u0026amp;A in target markets by an estimated 20% and helped grow international revenue to roughly 35% of total sales by Q4 2025, boosting penetration in emerging economies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital Systems and GPO Contracts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMasimo funnels much of its 2024 revenue through GPOs and IDNs, with GPO-contracted placements covering roughly 40–50% of U.S. hospital beds (~2,500–3,000 hospitals), making Masimo the preferred\/exclusive monitor for thousands of member hospitals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect-to-Consumer Digital Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpwith the expansion into consumer health and wearables masimo sells stork monitors non-prescription via its e-commerce site major marketplaces boosting direct-to-consumer reach lowering channel margins.\u003e\u003cpdigital sales accounted for an estimated of masimo consumer revenue in enabling direct data collection on usage and preferences faster product iteration.\u003e\u003cpthis channel supports agile marketing tests targeted ads and firmware updates time-to-market for feature changes by weeks.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDirect e-commerce + marketplaces\u003c\/li\u003e\n\u003cli\u003e~18% consumer digital revenue (2024)\u003c\/li\u003e\n\u003cli\u003eFaster product iteration, direct user data\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthis\u003e\u003c\/pdigital\u003e\u003c\/pwith\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegration with Healthcare IT Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMasimo places its monitoring and analytics inside hospital EMRs and telehealth platforms, making devices and software core to clinical workflows and raising switching costs; in 2024 Masimo reported software and connectivity revenue growth of ~18%, underscoring this shift.\u003c\/p\u003e\n\u003cp\u003eEmbedding real-time data streams turns Masimo into a recurring-data provider—hospitals that integrate its API see fewer vendor swaps and higher lifetime value, contributing to Masimo’s 2024 gross margin improvement to ~49%.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eIntegration into EMRs and telehealth\u003c\/li\u003e\n\u003cli\u003e2024 software\/connectivity rev +18%\u003c\/li\u003e\n\u003cli\u003eGross margin ~49% in 2024\u003c\/li\u003e\n\u003cli\u003eHigher switching costs via embedded workflows\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMasimo hybrid GTM: 60% direct, global distributors, 40–50% US beds, software lifts margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMasimo uses a hybrid go-to-market: direct sales in US\/EU (≈60% revenue 2024), distributors in APAC\/EMEA to scale, GPO\/IDN channels covering ~40–50% of U.S. hospital beds, and D2C e-commerce (≈18% of consumer revenue 2024); integration into EMRs\/telehealth raised software\/connectivity rev +18% and gross margin to ~49% in 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003eKey metric (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect sales\u003c\/td\u003e\n\u003ctd\u003e60% revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003eAPAC\/LatAm\/Middle East\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPO\/IDN\u003c\/td\u003e\n\u003ctd\u003e40–50% US beds\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eE‑commerce\u003c\/td\u003e\n\u003ctd\u003e18% consumer rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSoftware\/connectivity\u003c\/td\u003e\n\u003ctd\u003e+18% rev; GM ~49%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eMasimo 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual Masimo 4P's Marketing Mix Analysis you’ll receive instantly after purchase—fully complete, editable, and ready to use with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750063550841,"sku":"masimo-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/masimo-marketing-mix.png?v=1772221730","url":"https:\/\/growthsharematrix.com\/products\/masimo-marketing-mix","provider":"Growth Share Matrix","version":"1.0","type":"link"}